Fineotex Chemical Limited filed a revised Annual Report for FY26 on August 18, 2026, pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The revision was made solely to correct an inadvertent typographical error identified in the original report. The company confirmed that there is no change in financial results or any other material information contained in the Annual Report.

Revision Details

The revised Annual Report, including the Notice of the 23rd Annual General Meeting, is available on the company's website at https://fineotex.com/investor-relation/ . The filing was digitally signed by Sunny Parmar, Company Secretary and Compliance Officer, on August 18, 2026.

Key Financial Highlights (Unchanged)

As reported in the original Annual Report, Fineotex Chemical's consolidated income from operations stood at ₹77,222.56 lakhs in FY26, up 44.79% from ₹53,333.28 lakhs in FY25. Consolidated profit after tax (PAT) rose 14.50% to ₹12,501.51 lakhs from ₹10,920.82 lakhs. EBITDA on a consolidated basis amounted to ₹16,781.93 lakhs.

On a standalone basis, revenue from operations was ₹39,687.83 lakhs and PAT was ₹9,188.96 lakhs.

AGM and Corporate Action Dates

The 23rd AGM agenda and key corporate action dates remain unchanged, as summarised below.

Dividend and Capital Structure

The Board recommended a final dividend of ₹0.05 per equity share of face value ₹1 each for FY26, with a total payout of ₹582.25 lakhs. An interim dividend of ₹0.80 per equity share was declared in September 2025. The paid-up share capital as at March 31, 2026 stood at ₹116.45 crore comprising 116,45,00,900 equity shares of face value ₹1 each, following a stock split and a 4:1 bonus issue during FY26.

AGM Special Business

The 23rd AGM will consider the following special business items:

• Capital raising: Shareholder approval to raise up to ₹800 crore through equity shares or other eligible securities via QIP, preferential issue, FPO, or a combination thereof, for capital expenditure, working capital, general corporate purposes, and inorganic growth.
• Related party transactions: Approval for material related party transactions between Fineotex Biotex HealthGuard FZE and CrudeChem Technology LLC for FY26-27, capped at an aggregate value of ₹500 crore, comprising sale/purchase/supply of goods or services (up to ₹100 crore) and loans and advances (up to ₹400 crore).
• Cost auditor remuneration: Ratification of remuneration of ₹50,000 per annum plus applicable taxes and expenses payable to M/s V. J. Talati & Co. as cost auditor for FY26-27.
• Director re-appointment: Re-appointment of Mrs. Aarti Mitesh Jhunjhunwala (DIN: 07759722) as director, retiring by rotation.

Operational and Credit Highlights

During FY26, consolidated production volume stood at 81,731 MT compared with 60,692.40 MT in the prior year, while sales volume increased to 80,356.72 MT from 60,194.47 MT. In December 2025, Fineotex Biotex Healthguard FZE acquired a 53.33% equity stake in CrudeChem Technology LLC, a US-based specialty oilfield chemical manufacturer, marking the group's entry into the oilfield specialty chemicals segment.

ICRA reaffirmed the company's long-term credit rating at ICRA A+ (Positive) and short-term rating at ICRA A1+. The company was also honoured with the Business Excellence Award 2025 in the Chemicals (SME) category by Dun & Bradstreet and was certified as a "Great Place to Work" for the fourth consecutive time.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE045J01034/56b60c2e-4412-47ad-af83-2792747e20e4.pdf

Fineotex Chemical submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ending March 31, 2026, on August 18, 2026, in compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The speciality chemicals manufacturer reported a clean safety record for the fiscal year, with zero lost-time injury frequency rates and no fatalities among employees or workers. The company maintains an Occupational Health and Safety Management System aligned with ISO 45001 standards.

Operational Metrics

Fineotex operates six plants and one office nationally, with one international office. Its products serve customers in 14 Indian states and 70 countries. Exports contributed 15.30% to the total turnover for the period.

The company employs 120 permanent staff and 180 workers. Female representation stands at 25.83% among permanent employees and 8.89% among workers. The Board of Directors includes two women, accounting for 28.57% of the total board composition.

Environmental Performance

Total energy consumption rose to 1,827.41 GJ in FY26 from 1,793.52 GJ in the prior year. Renewable energy sources accounted for 340.98 GJ of this total. Water withdrawal increased to 50,080 kilolitres, up from 42,502 kilolitres previously.

Greenhouse gas emissions were disclosed for the first time in this reporting cycle. Scope 1 emissions totaled 162.36 metric tonnes of CO2 equivalent, while Scope 2 emissions reached 330.32 metric tonnes. The combined emission intensity was 1.24 MT per crore of turnover.

Governance and Ethics

The company reported no fines, penalties, or regulatory actions during the year. Zero complaints were received regarding conflict of interest, sexual harassment, or discrimination. All permanent employees and workers received training on human rights and health and safety measures.

Capital expenditure directed toward environmental and social impact improvements accounted for 3.17% of total capex in FY26, compared to nil in the previous year. This includes investments in air emission reduction, water conservation, and solar panel operations.